High Tech Pharm Co., Ltd. (KOSDAQ:106190)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,640
+470 (3.86%)
At close: Jul 3, 2026
Market Cap134.40B -2.8%
Revenue (ttm)69.05B -6.2%
Net Income9.02B -28.5%
EPS843.31 -29.0%
Shares Out 10.63M
PE Ratio14.99
Forward PEn/a
Dividend150.00 (1.23%)
Ex-Dividend DateDec 29, 2025
Volume15,093
Open12,270
Previous Close12,170
Day's Range11,900 - 12,650
52-Week Range10,700 - 25,000
Beta-0.09
Analystsn/a
Price Targetn/a
Earnings DateAug 13, 2026

About High Tech Pharm

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 106190
Full Company Profile

Financial Performance

In 2025, High Tech Pharm's revenue was 70.18 billion, a decrease of -9.46% compared to the previous year's 77.51 billion. Earnings were 11.48 billion, a decrease of -16.30%.

Financial Statements